{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:07:02Z","timestamp":1788822422711,"version":"build-2803163510"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-025-10171-z","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:50:59Z","timestamp":1738565459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review"],"prefix":"10.1007","volume":"20","author":[{"given":"Eman A.","family":"Alraddadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal F.","family":"Aljuhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadah Y.","family":"Alsamiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa Y.","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaida","family":"Alselami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniyah A.","family":"Almarghalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal F.","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"10171_CR1","doi-asserted-by":"publisher","first-page":"108935","DOI":"10.1016\/j.neuropharm.2021.108935","volume":"207","author":"SS Abdel Mageed","year":"2022","unstructured":"Abdel Mageed SS, Ammar RM, Nassar NN, Moawad H, Kamel AS (2022) Role of PI3K\/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat. Neuropharmacology 207:108935","journal-title":"Neuropharmacology"},{"key":"10171_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainres.2012.08.006","volume":"1477","author":"A Ahmad","year":"2012","unstructured":"Ahmad A, Genovese T, Impellizzeri D et al (2012) Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats. Brain Res 1477:45\u201358","journal-title":"Brain Res"},{"key":"10171_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4103\/1673-5374.301031","volume":"16","author":"FF Alamri","year":"2021","unstructured":"Alamri FF, Al Shoyaib A, Syeara N et al (2021a) Delayed atomoxetine or fluoxetine treatment coupled with limited voluntary running promotes motor recovery in mice after ischemic stroke. Neural Regen Res 16:1244\u20131251","journal-title":"Neural Regen Res"},{"issue":"7","key":"10171_CR4","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4103\/1673-5374.301031","volume":"16","author":"FF Alamri","year":"2021","unstructured":"Alamri FF, Al Shoyaib A, Syeara N, Paul A, Jayaraman S, Karamyan ST et al (2021b) Delayed atomoxetine or fluoxetine treatment coupled with limited voluntary running promotes motor recovery in mice after ischemic stroke. Neural Regen Res 16(7):1244\u20131251","journal-title":"Neural Regen Res"},{"issue":"6","key":"10171_CR5","doi-asserted-by":"publisher","first-page":"102082","DOI":"10.1016\/j.jsps.2024.102082","volume":"32","author":"FF Alamri","year":"2024","unstructured":"Alamri FF, Almarghalani DA, Alraddadi EA, Alharbi A, Algarni HS, Mulla OM et al (2024) The utility of serum glucose potassium ratio as a predictive factor for haemorrhagic transformation, stroke recurrence, and mortality among ischemic stroke patients. Saudi Pharm J 32(6):102082","journal-title":"Saudi Pharm J"},{"key":"10171_CR6","doi-asserted-by":"publisher","first-page":"951283","DOI":"10.3389\/fnins.2022.951283","volume":"16","author":"AR Alharbi","year":"2022","unstructured":"Alharbi AR, Alali AS, Samman Y, Alghamdi NA, Albaradie O, Almaghrabi M et al (2022) Vitamin D serum level predicts stroke clinical severity, functional independence, and disability-A retrospective cohort study. Front Neurosci 16:951283","journal-title":"Front Neurosci"},{"key":"10171_CR7","doi-asserted-by":"publisher","first-page":"109398","DOI":"10.1016\/j.cbi.2021.109398","volume":"336","author":"AM Ali","year":"2021","unstructured":"Ali AM, El-Tawil OS, Al-Mokaddem AK, Abd El-Rahman SS (2021) Promoted inhibition of TLR4\/miR-155\/ NF(k)B p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide. Chem Biol Interact 336:109398","journal-title":"Chem Biol Interact"},{"key":"10171_CR8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/ijms21041283","volume":"21","author":"D Alonso-Alconada","year":"2020","unstructured":"Alonso-Alconada D, Alvarez FJ, Goni-de-Cerio F, Hilario E, Alvarez A (2020) Cannabinoid-mediated Modulation of Oxidative Stress and Early Inflammatory Response after Hypoxia-Ischemia. Int J Mol Sci 21:1283","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10171_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11011-024-01508-3","volume":"40","author":"EA Alraddadi","year":"2024","unstructured":"Alraddadi EA, Alatawi Y, Kumar RS, Bukhari JI, Alghamdi AE, Lughbi S et al (2024) Insights into risk factors and outcomes of post-stroke seizures in Saudi Arabia: a multicenter analysis. Metab Brain Dis 40(1):72","journal-title":"Metab Brain Dis"},{"key":"10171_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jneuroim.2016.12.009","volume":"303","author":"P Annunziata","year":"2017","unstructured":"Annunziata P, Cioni C, Mugnaini C, Corelli F (2017) Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis. J Neuroimmunol 303:66\u201374","journal-title":"J Neuroimmunol"},{"key":"10171_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neulet.2006.10.053","volume":"412","author":"JC Ashton","year":"2007","unstructured":"Ashton JC, Rahman RM, Nair SM, Sutherland BA, Glass M, Appleton I (2007) Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain. Neurosci Lett 412:114\u2013117","journal-title":"Neurosci Lett"},{"key":"10171_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","volume":"71","author":"MP Baggelaar","year":"2018","unstructured":"Baggelaar MP, Maccarrone M, van der Stelt M (2018) 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. Prog Lipid Res 71:1\u201317","journal-title":"Prog Lipid Res"},{"key":"10171_CR13","doi-asserted-by":"publisher","first-page":"e29405","DOI":"10.1371\/journal.pone.0029405","volume":"6","author":"Y Bejot","year":"2011","unstructured":"Bejot Y, Mossiat C, Giroud M, Prigent-Tessier A, Marie C (2011) Circulating and brain BDNF levels in stroke rats. Relev Clin Stud Plos One 6:e29405","journal-title":"Relev Clin Stud Plos One"},{"key":"10171_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/ph15101166","volume":"15","author":"A Benedicto","year":"2022","unstructured":"Benedicto A, Arteta B, Duranti A, Alonso-Alconada D (2022) The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer. Pharmaceuticals (Basel) 15:1166","journal-title":"Pharmaceuticals (Basel)"},{"key":"10171_CR15","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/biomedicines11061546","volume":"11","author":"V Borgonetti","year":"2023","unstructured":"Borgonetti V, Mugnaini C, Corelli F, Galeotti N (2023) The Selective CB2 Agonist COR167 Reduced Symptoms in a Mice Model of Trauma-Induced Peripheral Neuropathy through HDAC-1 Inhibition. Biomedicines 11:1546","journal-title":"Biomedicines"},{"issue":"9","key":"10171_CR16","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1161\/STROKEAHA.117.017112","volume":"48","author":"F Bosetti","year":"2017","unstructured":"Bosetti F, Koenig JI, Ayata C, Back SA, Becker K, Broderick JP et al (2017) Translational Stroke Research: Vision and Opportunities. Stroke 48(9):2632\u20132637","journal-title":"Stroke"},{"key":"10171_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.596601","volume":"12","author":"J Bourque","year":"2021","unstructured":"Bourque J, Potvin S (2021) Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs. Front Psychiatry 12:596601","journal-title":"Front Psychiatry"},{"key":"10171_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/00498254.2011.609570","volume":"42","author":"LK Brents","year":"2012","unstructured":"Brents LK, Medina-Bolivar F, Seely KA et al (2012) Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica 42:139\u2013156","journal-title":"Xenobiotica"},{"key":"10171_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","volume":"419","author":"A Calignano","year":"2001","unstructured":"Calignano A, La Rana G, Piomelli D (2001) Antinociceptive activity of the endogenous fatty acid amide, palmitoylethanolamide. Eur J Pharmacol 419:191\u2013198","journal-title":"Eur J Pharmacol"},{"key":"10171_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/jnc.13288","volume":"135","author":"L Caltana","year":"2015","unstructured":"Caltana L, Saez TM, Aronne MP, Brusco A (2015) Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice. J Neurochem 135:616\u2013629","journal-title":"J Neurochem"},{"key":"10171_CR21","first-page":"4784","volume":"16","author":"Q Cao","year":"2018","unstructured":"Cao Q, Liu X, Yang F, Wang H (2018) CB2R induces a protective response for epileptic seizure via the PI3K 110alpha-AKT signaling pathway. Exp Ther Med 16:4784\u20134790","journal-title":"Exp Ther Med"},{"key":"10171_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1021\/acschemneuro.0c00047","volume":"11","author":"S Carloni","year":"2020","unstructured":"Carloni S, Crinelli R, Palma L et al (2020) The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination after Hypoxia-Ischemia in Neonatal Rats. ACS Chem Neurosci 11:1291\u20131299","journal-title":"ACS Chem Neurosci"},{"key":"10171_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neuropharm.2016.12.017","volume":"116","author":"M Ceprian","year":"2017","unstructured":"Ceprian M, Jimenez-Sanchez L, Vargas C, Barata L, Hind W, Martinez-Orgado J (2017) Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke. Neuropharmacology 116:151\u2013159","journal-title":"Neuropharmacology"},{"key":"10171_CR24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","volume":"2","author":"R Chen","year":"2012","unstructured":"Chen R, Zhang J, Wu Y et al (2012) Monoacylglycerol lipase is a therapeutic target for Alzheimer s disease. Cell Rep 2:1329\u20131339","journal-title":"Cell Rep"},{"key":"10171_CR25","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1248\/bpb.b19-00394","volume":"42","author":"L Cheng","year":"2019","unstructured":"Cheng L, Li J, Zhou Y, Zheng Q, Ming X, Liu S (2019) N-Linoleyltyrosine Protects against Transient Cerebral Ischemia in Gerbil via CB2 Receptor Involvement in PI3K\/Akt Signaling Pathway. Biol Pharm Bull 42:1867\u20131876","journal-title":"Biol Pharm Bull"},{"key":"10171_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000338755","volume":"89","author":"OZ Chi","year":"2012","unstructured":"Chi OZ, Barsoum S, Grayson J, Hunter C, Liu X, Weiss HR (2012) Effects of cannabinoid receptor agonist WIN 55,212\u20132 on blood-brain barrier disruption in focal cerebral ischemia in rats. Pharmacology 89:333\u2013338","journal-title":"Pharmacology"},{"key":"10171_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imm.12441","volume":"144","author":"V Chiurchiu","year":"2015","unstructured":"Chiurchiu V, Battistini L, Maccarrone M (2015) Endocannabinoid signalling in innate and adaptive immunity. Immunology 144:352\u2013364","journal-title":"Immunology"},{"key":"10171_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","volume":"182","author":"IY Choi","year":"2013","unstructured":"Choi IY, Ju C, Anthony Jalin AM, Lee DI, Prather PL, Kim WK (2013) Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury. Am J Pathol 182:928\u2013939","journal-title":"Am J Pathol"},{"key":"10171_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1871524919666190923154351","volume":"19","author":"C Cioni","year":"2019","unstructured":"Cioni C, Tassi M, Marotta G, Mugnaini C, Corelli F, Annunziata P (2019) A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors. Cent Nerv Syst Agents Med Chem 19:206\u2013214","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10171_CR30","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.3390\/ijms22105305","volume":"22","author":"P Clayton","year":"2021","unstructured":"Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R (2021) Palmitoylethanolamide: A Natural Compound for Health Management. Int J Mol Sci 22:5305","journal-title":"Int J Mol Sci"},{"key":"10171_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121838","volume":"329","author":"MP Coelho","year":"2023","unstructured":"Coelho MP, Duarte P, Calado M, Almeida AJ, Reis CP, Gaspar MM (2023) The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential. Life Sci 329:121838","journal-title":"Life Sci"},{"key":"10171_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBDS Collaborators","year":"2021","unstructured":"Collaborators GBDS (2021) Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20:795\u2013820","journal-title":"Lancet Neurol"},{"key":"10171_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.phrs.2012.08.003","volume":"66","author":"A Contartese","year":"2012","unstructured":"Contartese A, Valoti M, Corelli F et al (2012) A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury. Pharmacol Res 66:555\u2013563","journal-title":"Pharmacol Res"},{"key":"10171_CR34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ibd\/izy014","volume":"24","author":"DG Couch","year":"2018","unstructured":"Couch DG, Maudslay H, Doleman B, Lund JN, O Sullivan SE (2018) The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis 24:680\u2013697","journal-title":"Inflamm Bowel Dis"},{"issue":"8\u20139","key":"10171_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.lfs.2012.06.009","volume":"92","author":"RM Craft","year":"2013","unstructured":"Craft RM, Marusich JA, Wiley JL (2013) Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci 92(8\u20139):476\u2013481","journal-title":"Life Sci"},{"key":"10171_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s12640-018-9991-2","volume":"35","author":"F Crunfli","year":"2019","unstructured":"Crunfli F, Vrechi TA, Costa AP, Torrao AS (2019) Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation. Neurotox Res 35:516\u2013529","journal-title":"Neurotox Res"},{"key":"10171_CR37","first-page":"294","volume":"5","author":"DN Doll","year":"2014","unstructured":"Doll DN, Barr TL, Simpkins JW (2014) Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis 5:294\u2013306","journal-title":"Aging Dis"},{"issue":"4","key":"10171_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1208\/s12248-021-00616-7","volume":"23","author":"PT Doohan","year":"2021","unstructured":"Doohan PT, Oldfield LD, Arnold JC, Anderson LL (2021) Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization. AAPS J 23(4):91","journal-title":"AAPS J"},{"key":"10171_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/jcbfm.2014.218","volume":"35","author":"TJ England","year":"2015","unstructured":"England TJ, Hind WH, Rasid NA, O Sullivan SE (2015) Cannabinoids in experimental stroke: a systematic review and meta-analysis. J Cereb Blood Flow Metab 35:348\u2013358","journal-title":"J Cereb Blood Flow Metab"},{"key":"10171_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuroscience.2012.01.008","volume":"207","author":"D Fernandez-Lopez","year":"2012","unstructured":"Fernandez-Lopez D, Faustino J, Derugin N et al (2012) Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212\u20132 after neonatal stroke. Neuroscience 207:307\u2013315","journal-title":"Neuroscience"},{"key":"10171_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","volume":"12","author":"J Fernandez-Ruiz","year":"2015","unstructured":"Fernandez-Ruiz J, Moro MA, Martinez-Orgado J (2015) Cannabinoids in Neurodegenerative Disorders and Stroke\/Brain Trauma: From Preclinical Models to Clinical Applications. Neurotherapeutics 12:793\u2013806","journal-title":"Neurotherapeutics"},{"key":"10171_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S1474-4422(19)30032-8","volume":"18","author":"D Friedman","year":"2019","unstructured":"Friedman D, French JA, Maccarrone M (2019) Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol 18:504\u2013512","journal-title":"Lancet Neurol"},{"key":"10171_CR43","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.1038\/s41598-021-89629-y","volume":"11","author":"B Garrone","year":"2021","unstructured":"Garrone B, Durando L, Prenderville J et al (2021) Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats. Sci Rep 11:10139","journal-title":"Sci Rep"},{"key":"10171_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.21470\/1678-9741-2017-0218","volume":"33","author":"O Geldi","year":"2018","unstructured":"Geldi O, Kubat E, Unal CS, Canbaz S (2018) Acetaminophen Mitigates Myocardial Injury Induced by Lower Extremity Ischemia-Reperfusion in Rat Model. Braz J Cardiovasc Surg 33:258\u2013264","journal-title":"Braz J Cardiovasc Surg"},{"key":"10171_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1476-5381.2010.00745.x","volume":"160","author":"J Gertsch","year":"2010","unstructured":"Gertsch J, Pertwee RG, Di Marzo V (2010) Phytocannabinoids beyond the Cannabis plant - do they exist? Br J Pharmacol 160:523\u2013529","journal-title":"Br J Pharmacol"},{"key":"10171_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-030-57369-0_7","volume":"1264","author":"V Golub","year":"2021","unstructured":"Golub V, Reddy DS (2021) Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders. Adv Exp Med Biol 1264:93\u2013110","journal-title":"Adv Exp Med Biol"},{"key":"10171_CR47","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3390\/molecules25071567","volume":"25","author":"ECD Goncalves","year":"2020","unstructured":"Goncalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC (2020) Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant. Molecules 25:1567","journal-title":"Molecules"},{"key":"10171_CR48","first-page":"230","volume":"19","author":"B Goren","year":"2009","unstructured":"Goren B, Mimbay Z, Bilici N, Zarifoglu M, Ogul E, Korfali E (2009) Investigation of neuroprotective effects of cyclooxygenase inhibitors in the 6-hydroxydopamine induced rat Parkinson model. Turk Neurosurg 19:230\u2013236","journal-title":"Turk Neurosurg"},{"key":"10171_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12031-014-0243-5","volume":"54","author":"K Guo","year":"2014","unstructured":"Guo K, Mou X, Huang J, Xiong N, Li H (2014) Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory responses by inhibiting NF-kappaB activation in microglia. J Mol Neurosci 54:41\u201348","journal-title":"J Mol Neurosci"},{"key":"10171_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fped.2020.00065","volume":"8","author":"B Gupta","year":"2020","unstructured":"Gupta B, Hornick MG, Briyal S, Donovan R, Prazad P, Gulati A (2020) Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy. Front Pediatr 8:65","journal-title":"Front Pediatr"},{"key":"10171_CR51","doi-asserted-by":"publisher","first-page":"174398","DOI":"10.1016\/j.ejphar.2021.174398","volume":"909","author":"HM Hashiesh","year":"2021","unstructured":"Hashiesh HM, Jha NK, Sharma C et al (2021a) Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases. Eur J Pharmacol 909:174398","journal-title":"Eur J Pharmacol"},{"key":"10171_CR52","doi-asserted-by":"publisher","first-page":"702675","DOI":"10.3389\/fphar.2021.702675","volume":"12","author":"HM Hashiesh","year":"2021","unstructured":"Hashiesh HM, Sharma C, Goyal SN, Jha NK, Ojha S (2021b) Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist. Front Pharmacol 12:702675","journal-title":"Front Pharmacol"},{"key":"10171_CR53","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0022-3565(24)38289-8","volume":"289","author":"CJ Hillard","year":"1999","unstructured":"Hillard CJ, Manna S, Greenberg MJ et al (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289:1427\u20131433","journal-title":"J Pharmacol Exp Ther"},{"key":"10171_CR54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bph.13368","volume":"173","author":"WH Hind","year":"2016","unstructured":"Hind WH, England TJ, O Sullivan SE (2016) Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARgamma and 5-HT1A receptors. Br J Pharmacol 173:815\u2013825","journal-title":"Br J Pharmacol"},{"key":"10171_CR55","first-page":"1","volume":"19","author":"E Hoch","year":"2024","unstructured":"Hoch E, Volkow ND, Friemel CM, Lorenzetti V, Freeman TP, Hall W (2024) Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur Arch Psychiatry Clin Neurosci. 19:1\u20132","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"10171_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI et al (2002) International Union of Pharmacology. XXVII Classification of cannabinoid receptors. Pharmacol Rev 54:161\u2013202","journal-title":"Pharmacol Rev"},{"key":"10171_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1476-5381.2010.01046.x","volume":"162","author":"GC Hsieh","year":"2011","unstructured":"Hsieh GC, Pai M, Chandran P et al (2011) Central and peripheral sites of action for CB(2) receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats. Br J Pharmacol 162:428\u2013440","journal-title":"Br J Pharmacol"},{"key":"10171_CR58","doi-asserted-by":"publisher","first-page":"1164367","DOI":"10.3389\/fphar.2023.1164367","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu Y, Zhao Z, Liu YT et al (2023) N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB(1) and CB(2) involvement of PI3K and ERK pathways. Front Pharmacol 14:1164367","journal-title":"Front Pharmacol"},{"key":"10171_CR59","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2174\/1570159X18666200620230321","volume":"18","author":"Y Huang","year":"2020","unstructured":"Huang Y, Chen S, Luo Y, Han Z (2020) Crosstalk between Inflammation and the BBB in Stroke. Curr Neuropharmacol 18:1227\u20131236","journal-title":"Curr Neuropharmacol"},{"key":"10171_CR60","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1016\/S0968-0896(99)00219-9","volume":"7","author":"JW Huffman","year":"1999","unstructured":"Huffman JW, Liddle J, Yu S et al (1999) 3-(1 ,1 -Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg Med Chem 7:2905\u20132914","journal-title":"Bioorg Med Chem"},{"key":"10171_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","volume":"76","author":"SI Jaggar","year":"1998","unstructured":"Jaggar SI, Hasnie FS, Sellaturay S, Rice AS (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189\u2013199","journal-title":"Pain"},{"key":"10171_CR62","doi-asserted-by":"publisher","first-page":"e0141600","DOI":"10.1371\/journal.pone.0141600","volume":"10","author":"AM Jalin","year":"2015","unstructured":"Jalin AM, Rajasekaran M, Prather PL et al (2015) Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia\/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity. PLoS ONE 10:e0141600","journal-title":"PLoS ONE"},{"key":"10171_CR63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA (2019) Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation 16:142","journal-title":"J Neuroinflammation"},{"key":"10171_CR64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/1531-8249(200008)48:2<257::AID-ANA18>3.0.CO;2-P","volume":"48","author":"KL Jin","year":"2000","unstructured":"Jin KL, Mao XO, Goldsmith PC, Greenberg DA (2000) CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol 48:257\u2013261","journal-title":"Ann Neurol"},{"key":"10171_CR65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuropharm.2012.12.006","volume":"67","author":"C Ju","year":"2013","unstructured":"Ju C, Hwang S, Cho GS et al (2013) Differential anti-ischemic efficacy and therapeutic time window of trans- and cis-hinokiresinols: stereo-specific antioxidant and anti-inflammatory activities. Neuropharmacology 67:465\u2013475","journal-title":"Neuropharmacology"},{"key":"10171_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-0716-2926-0_25","volume":"2616","author":"VT Karamyan","year":"2023","unstructured":"Karamyan VT (2023) Clinically Applicable Experimental Design and Considerations for Stroke Recovery Preclinical Studies. Methods Mol Biol 2616:369\u2013377","journal-title":"Methods Mol Biol"},{"key":"10171_CR67","doi-asserted-by":"publisher","first-page":"139","DOI":"10.18869\/nirp.bcn.8.2.139","volume":"8","author":"S Khaksar","year":"2017","unstructured":"Khaksar S, Bigdeli MR (2017) Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model. Basic Clin Neurosci 8:139\u2013146","journal-title":"Basic Clin Neurosci"},{"key":"10171_CR68","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainresbull.2022.01.001","volume":"180","author":"S Khaksar","year":"2022","unstructured":"Khaksar S, Bigdeli M, Samiee A, Shirazi-Zand Z (2022) Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats. Brain Res Bull 180:118\u2013130","journal-title":"Brain Res Bull"},{"key":"10171_CR69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pnpbp.2015.10.010","volume":"66","author":"MD Knowles","year":"2016","unstructured":"Knowles MD, de la Tremblaye PB, Azogu I, Plamondon H (2016) Endocannabinoid CB1 receptor activation upon global ischemia adversely impact recovery of reward and stress signaling molecules, neuronal survival and behavioral impulsivity. Prog Neuropsychopharmacol Biol Psychiatry 66:8\u201321","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10171_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/glia.10151","volume":"40","author":"M Koistinaho","year":"2002","unstructured":"Koistinaho M, Koistinaho J (2002) Role of p38 and p44\/42 mitogen-activated protein kinases in microglia. Glia 40:175\u2013183","journal-title":"Glia"},{"key":"10171_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbrc.2021.06.019","volume":"566","author":"D Kong","year":"2021","unstructured":"Kong D, Xie B, Li Y, Xu Y (2021) PEA prevented early BBB disruption after cerebral ischaemic\/reperfusion (I\/R) injury through regulation of ROCK\/MLC signaling. Biochem Biophys Res Commun 566:164\u2013169","journal-title":"Biochem Biophys Res Commun"},{"key":"10171_CR72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1479-5876-7-97","volume":"7","author":"SE Lakhan","year":"2009","unstructured":"Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97","journal-title":"J Transl Med"},{"key":"10171_CR73","doi-asserted-by":"crossref","unstructured":"Le Foll B, Tang VM, Rueda S, Trick LV, Boileau I (2024) Cannabis use disorder: from neurobiology to treatment. J Clin Invest 134(20).","DOI":"10.1172\/JCI172887"},{"key":"10171_CR74","doi-asserted-by":"publisher","first-page":"172950","DOI":"10.1016\/j.pbb.2020.172950","volume":"194","author":"M Leija-Salazar","year":"2020","unstructured":"Leija-Salazar M, Bermudez de Leon M, Gonzalez-Horta A, Gonzalez-Hernandez B (2020) Arachidonyl-2 -chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB(1)R gene expression and reduces dyskinesias in a rat model of Parkinson s disease. Pharmacol Biochem Behav 194:172950","journal-title":"Pharmacol Biochem Behav"},{"key":"10171_CR75","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12975-015-0425-7","volume":"6","author":"L Li","year":"2015","unstructured":"Li L, Tao Y, Tang J et al (2015) A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats. Transl Stroke Res 6:467\u2013477","journal-title":"Transl Stroke Res"},{"key":"10171_CR76","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1159\/000447855","volume":"39","author":"X Li","year":"2016","unstructured":"Li X, Han D, Tian Z et al (2016) Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-beta1\/Smad3 Pathway in Myocardial Infarction Mice. Cell Physiol Biochem 39:1521\u20131536","journal-title":"Cell Physiol Biochem"},{"key":"10171_CR77","doi-asserted-by":"publisher","first-page":"850866","DOI":"10.3389\/fncel.2022.850866","volume":"16","author":"L Li","year":"2022","unstructured":"Li L, Zhou J, Han L et al (2022a) The Specific Role of Reactive Astrocytes in Stroke. Front Cell Neurosci 16:850866","journal-title":"Front Cell Neurosci"},{"key":"10171_CR78","doi-asserted-by":"publisher","first-page":"113899","DOI":"10.1016\/j.expneurol.2021.113899","volume":"347","author":"L Li","year":"2022","unstructured":"Li L, Luo Q, Shang B et al (2022b) Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury. Exp Neurol 347:113899","journal-title":"Exp Neurol"},{"key":"10171_CR79","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2008.04.058","volume":"438","author":"HW Liang","year":"2008","unstructured":"Liang HW, Qiu SF, Shen J et al (2008) Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci Lett 438:116\u2013120","journal-title":"Neurosci Lett"},{"key":"10171_CR80","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.brainres.2010.02.037","volume":"1325","author":"Q Lin","year":"2010","unstructured":"Lin Q, Hai J, Yao LY, Lu Y (2010) Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion. Brain Res 1325:183\u2013190","journal-title":"Brain Res"},{"key":"10171_CR81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fimmu.2017.00112","volume":"8","author":"L Lin","year":"2017","unstructured":"Lin L, Yihao T, Zhou F et al (2017) Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage. Front Immunol 8:112","journal-title":"Front Immunol"},{"key":"10171_CR82","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/apha.12848","volume":"219","author":"Q Liu","year":"2017","unstructured":"Liu Q, Gonzales RJ (2017) Targeting mitogen-activated protein kinase in acute ischaemic stroke. Acta Physiol (Oxf) 219:712\u2013714","journal-title":"Acta Physiol (Oxf)"},{"key":"10171_CR83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12177-008-9009-z","volume":"1","author":"MG Liu","year":"2008","unstructured":"Liu MG, Li H, Xu X, Barnstable CJ, Zhang SS (2008) Comparison of gene expression during in vivo and in vitro postnatal retina development. J Ocul Biol Dis Infor 1:59\u201372","journal-title":"J Ocul Biol Dis Infor"},{"key":"10171_CR84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jphs.2016.08.009","volume":"132","author":"S Liu","year":"2016","unstructured":"Liu S, Tang SQ, Cui HJ et al (2016) Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer s disease. J Pharmacol Sci 132:92\u201399","journal-title":"J Pharmacol Sci"},{"key":"10171_CR85","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.chembiol.2009.05.009","volume":"16","author":"JZ Long","year":"2009","unstructured":"Long JZ, Nomura DK, Cravatt BF (2009) Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem Biol 16:744\u2013753","journal-title":"Chem Biol"},{"key":"10171_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jphs.2021.08.008","volume":"147","author":"CM Long","year":"2021","unstructured":"Long CM, Zheng QX, Zhou Y et al (2021) N-linoleyltyrosine exerts neuroprotective effects in APP\/PS1 transgenic mice via cannabinoid receptor-mediated autophagy. J Pharmacol Sci 147:315\u2013324","journal-title":"J Pharmacol Sci"},{"key":"10171_CR87","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bmcl.2008.12.059","volume":"19","author":"J LoVerme","year":"2009","unstructured":"LoVerme J, Duranti A, Tontini A et al (2009) Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice. Bioorg Med Chem Lett 19:639\u2013643","journal-title":"Bioorg Med Chem Lett"},{"key":"10171_CR88","doi-asserted-by":"publisher","first-page":"R871","DOI":"10.1152\/ajpregu.00031.2010","volume":"299","author":"Y Ma","year":"2010","unstructured":"Ma Y, Sullivan JC, Schreihofer DA (2010) Dietary genistein and equol (4 , 7 isoflavandiol) reduce oxidative stress and protect rats against focal cerebral ischemia. Am J Physiol Regul Integr Comp Physiol 299:R871-877","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10171_CR89","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/cns.12302","volume":"20","author":"L Ma","year":"2014","unstructured":"Ma L, Wang L, Yang F et al (2014) Disease-modifying effects of RHC80267 and JZL184 in a pilocarpine mouse model of temporal lobe epilepsy. CNS Neurosci Ther 20:905\u2013915","journal-title":"CNS Neurosci Ther"},{"key":"10171_CR90","doi-asserted-by":"publisher","first-page":"12440","DOI":"10.1038\/srep12440","volume":"5","author":"L Ma","year":"2015","unstructured":"Ma L, Jia J, Niu W et al (2015) Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions. Sci Rep 5:12440","journal-title":"Sci Rep"},{"key":"10171_CR91","first-page":"001","volume":"1","author":"DW Maixner","year":"2013","unstructured":"Maixner DW, Weng HR (2013) The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain. J Pharm Pharmacol (Los Angel) 1:001","journal-title":"J Pharm Pharmacol (Los Angel)"},{"key":"10171_CR92","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cbi.2019.02.028","volume":"304","author":"MFN Meeran","year":"2019","unstructured":"Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S (2019) beta-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB(2)) receptors in rats. Chem Biol Interact 304:158\u2013167","journal-title":"Chem Biol Interact"},{"key":"10171_CR93","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1248\/cpb.48.389","volume":"48","author":"E Minami","year":"2000","unstructured":"Minami E, Taki M, Takaishi S, Iijima Y, Tsutsumi S, Akiyama T (2000) Stereochemistry of cis- and trans-hinokiresinol and their estrogen-like activity. Chem Pharm Bull (Tokyo) 48:389\u2013392","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10171_CR94","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","volume":"36","author":"K Mishima","year":"2005","unstructured":"Mishima K, Hayakawa K, Abe K et al (2005) Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36:1077\u20131082","journal-title":"Stroke"},{"key":"10171_CR95","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.3390\/ijms21228870","volume":"21","author":"J Mlost","year":"2020","unstructured":"Mlost J, Bryk M, Starowicz K (2020) Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. Int J Mol Sci 21:8870","journal-title":"Int J Mol Sci"},{"key":"10171_CR96","doi-asserted-by":"publisher","first-page":"101194","DOI":"10.1016\/j.plipres.2022.101194","volume":"89","author":"ED Mock","year":"2023","unstructured":"Mock ED, Gagestein B, van der Stelt M (2023) Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. Prog Lipid Res 89:101194","journal-title":"Prog Lipid Res"},{"key":"10171_CR97","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pnpbp.2016.11.005","volume":"75","author":"MA Mori","year":"2017","unstructured":"Mori MA, Meyer E, Soares LM, Milani H, Guimaraes FS, de Oliveira RMW (2017) Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. Prog Neuropsychopharmacol Biol Psychiatry 75:94\u2013105","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10171_CR98","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67:181\u2013198","journal-title":"Neuron"},{"key":"10171_CR99","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/bph.12411","volume":"171","author":"N Murataeva","year":"2014","unstructured":"Murataeva N, Straiker A, Mackie K (2014) Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. Br J Pharmacol 171:1379\u20131391","journal-title":"Br J Pharmacol"},{"key":"10171_CR100","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.neuroscience.2004.08.044","volume":"129","author":"S Muthian","year":"2004","unstructured":"Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ (2004) Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience 129:743\u2013750","journal-title":"Neuroscience"},{"key":"10171_CR101","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000139488","volume":"54","author":"K Nakamoto","year":"1997","unstructured":"Nakamoto K, Kamisaki Y, Wada K, Kawasaki H, Itoh T (1997) Protective effect of acetaminophen against acute gastric mucosal lesions induced by ischemia-reperfusion in the rat. Pharmacology 54:203\u2013210","journal-title":"Pharmacology"},{"key":"10171_CR102","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/glia.22930","volume":"64","author":"DM Norden","year":"2016","unstructured":"Norden DM, Trojanowski PJ, Villanueva E, Navarro E, Godbout JP (2016) Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge. Glia 64:300\u2013316","journal-title":"Glia"},{"key":"10171_CR103","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2174\/1570159X18666200528143301","volume":"18","author":"T Okada","year":"2020","unstructured":"Okada T, Suzuki H, Travis ZD, Zhang JH (2020) The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target. Curr Neuropharmacol 18:1187\u20131212","journal-title":"Curr Neuropharmacol"},{"key":"10171_CR104","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3390\/ijms23063344","volume":"23","author":"C Pagano","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C (2022) Cannabinoids Therapeutic Use in Clinical Practice. Int J Mol Sci 23:3344","journal-title":"Int J Mol Sci"},{"key":"10171_CR105","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cells8050437","volume":"8","author":"E Parrella","year":"2019","unstructured":"Parrella E, Porrini V, Benarese M, Pizzi M (2019) The Role of Mast Cells in Stroke. Cells 8:437","journal-title":"Cells"},{"key":"10171_CR106","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P (2015) Necroptosis and its role in inflammation. Nature 517:311\u2013320","journal-title":"Nature"},{"key":"10171_CR107","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1021\/jm800552f","volume":"51","author":"S Pasquini","year":"2008","unstructured":"Pasquini S, Botta L, Semeraro T et al (2008) Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo. J Med Chem 51:5075\u20135084","journal-title":"J Med Chem"},{"key":"10171_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13643-018-0934-z","volume":"8","author":"MB Passavanti","year":"2019","unstructured":"Passavanti MB, Alfieri A, Pace MC et al (2019) Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review. Syst Rev 8:9","journal-title":"Syst Rev"},{"key":"10171_CR109","first-page":"73","volume":"5","author":"AR Patel","year":"2013","unstructured":"Patel AR, Ritzel R, McCullough LD, Liu F (2013) Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol 5:73\u201390","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10171_CR110","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","volume":"63","author":"MR Pazos","year":"2012","unstructured":"Pazos MR, Cinquina V, Gomez A et al (2012) Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology 63:776\u2013783","journal-title":"Neuropharmacology"},{"key":"10171_CR111","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-030-57369-0_6","volume":"1264","author":"C Perez-Olives","year":"2021","unstructured":"Perez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R (2021) Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer s, Parkinson s, and Huntington s Diseases. Adv Exp Med Biol 1264:81\u201392","journal-title":"Adv Exp Med Biol"},{"key":"10171_CR112","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.13580","volume":"174","author":"S Petrosino","year":"2017","unstructured":"Petrosino S, Di Marzo V (2017) The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol 174:1349\u20131365","journal-title":"Br J Pharmacol"},{"key":"10171_CR113","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5498\/wjp.v12.i1.77","volume":"12","author":"GA Porter","year":"2022","unstructured":"Porter GA, O Connor JC (2022) Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime? World J Psychiatry 12:77\u201397","journal-title":"World J Psychiatry"},{"key":"10171_CR114","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/0271678X16685105","volume":"37","author":"G Pottier","year":"2017","unstructured":"Pottier G, Gomez-Vallejo V, Padro D et al (2017) PET imaging of cannabinoid type 2 receptors with [(11)C]A-836339 did not evidence changes following neuroinflammation in rats. J Cereb Blood Flow Metab 37:1163\u20131178","journal-title":"J Cereb Blood Flow Metab"},{"key":"10171_CR115","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13643-019-1243-x","volume":"8","author":"M Pratt","year":"2019","unstructured":"Pratt M, Stevens A, Thuku M et al (2019) Benefits and harms of medical cannabis: a scoping review of systematic reviews. Syst Rev 8:320","journal-title":"Syst Rev"},{"key":"10171_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.782569","volume":"12","author":"L Przykaza","year":"2021","unstructured":"Przykaza L (2021) Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia\/Reperfusion Cascade. Front Immunol 12:782569","journal-title":"Front Immunol"},{"key":"10171_CR117","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12264-019-00388-3","volume":"35","author":"C Qin","year":"2019","unstructured":"Qin C, Zhou LQ, Ma XT et al (2019) Dual Functions of Microglia in Ischemic Stroke. Neurosci Bull 35:921\u2013933","journal-title":"Neurosci Bull"},{"key":"10171_CR118","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lfs.2018.02.036","volume":"198","author":"MR Rahmani","year":"2018","unstructured":"Rahmani MR, Shamsizadeh A, Moghadam-Ahmadi A, Kaeidi A, Allahtavakoli M (2018a) Monoacylglycerol lipase inhibitor, JZL-184, confers neuroprotection in the mice middle cerebral artery occlusion model of stroke. Life Sci 198:143\u2013148","journal-title":"Life Sci"},{"key":"10171_CR119","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.biopha.2018.05.001","volume":"103","author":"MR Rahmani","year":"2018","unstructured":"Rahmani MR, Shamsizadeh A, Moghadam-Ahmadi A, Bazmandegan G, Allahtavakoli M (2018b) JZL184, as a monoacylglycerol lipase inhibitor, down-regulates inflammation in a cannabinoid pathway dependent manner. Biomed Pharmacother 103:1720\u20131726","journal-title":"Biomed Pharmacother"},{"key":"10171_CR120","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2016.07.041","volume":"630","author":"ZW Reichenbach","year":"2016","unstructured":"Reichenbach ZW, Li H, Ward SJ, Tuma RF (2016) The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia. Neurosci Lett 630:9\u201315","journal-title":"Neurosci Lett"},{"key":"10171_CR121","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fphys.2018.00622","volume":"9","author":"JS Richter","year":"2018","unstructured":"Richter JS, Quenardelle V, Rouyer O, Raul JS, Beaujeux R, Geny B et al (2018) A Systematic Review of the Complex Effects of Cannabinoids on Cerebral and Peripheral Circulation in Animal Models. Front Physiol 9:622","journal-title":"Front Physiol"},{"key":"10171_CR122","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lfs.2015.05.005","volume":"138","author":"RD Ronca","year":"2015","unstructured":"Ronca RD, Myers AM, Ganea D, Tuma RF, Walker EA, Ward SJ (2015) A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice. Life Sci 138:72\u201377","journal-title":"Life Sci"},{"key":"10171_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/stke.1999.5.re1","volume":"1999","author":"DM Rothwarf","year":"1999","unstructured":"Rothwarf DM, Karin M (1999) The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999:1","journal-title":"Sci STKE"},{"key":"10171_CR124","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1161\/01.STR.0000023491.63693.18","volume":"33","author":"WR Schabitz","year":"2002","unstructured":"Schabitz WR, Giuffrida A, Berger C et al (2002) Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33:2112\u20132114","journal-title":"Stroke"},{"key":"10171_CR125","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1111\/j.1476-5381.2011.01467.x","volume":"165","author":"M Scherma","year":"2012","unstructured":"Scherma M, Justinova Z, Zanettini C et al (2012) The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. Br J Pharmacol 165:2539\u20132548","journal-title":"Br J Pharmacol"},{"key":"10171_CR126","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12640-014-9457-0","volume":"26","author":"AP Schiavon","year":"2014","unstructured":"Schiavon AP, Soares LM, Bonato JM, Milani H, Guimaraes FS, Weffort de Oliveira RM (2014) Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice. Neurotox Res 26:307\u2013316","journal-title":"Neurotox Res"},{"key":"10171_CR127","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/164_2019_298","volume":"258","author":"LD Schurman","year":"2020","unstructured":"Schurman LD, Lu D, Kendall DA, Howlett AC, Lichtman AH (2020) Molecular Mechanism and Cannabinoid Pharmacology. Handb Exp Pharmacol 258:323\u2013353","journal-title":"Handb Exp Pharmacol"},{"key":"10171_CR128","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.3390\/ijms23073633","volume":"23","author":"MP Serra","year":"2022","unstructured":"Serra MP, Boi M, Carta A et al (2022) Anti-Inflammatory Effect of Beta-Caryophyllene Mediated by the Involvement of TRPV1, BDNF and trkB in the Rat Cerebral Cortex after Hypoperfusion\/Reperfusion. Int J Mol Sci 23:3633","journal-title":"Int J Mol Sci"},{"key":"10171_CR129","doi-asserted-by":"publisher","first-page":"755955","DOI":"10.3389\/fncel.2021.755955","volume":"15","author":"XY Shen","year":"2021","unstructured":"Shen XY, Gao ZK, Han Y, Yuan M, Guo YS, Bi X (2021) Activation and Role of Astrocytes in Ischemic Stroke. Front Cell Neurosci 15:755955","journal-title":"Front Cell Neurosci"},{"key":"10171_CR130","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00296-013-2943-5","volume":"34","author":"AP Simao","year":"2014","unstructured":"Simao AP, Mendonca VA, de Oliveira Almeida TM et al (2014) Involvement of BDNF in knee osteoarthritis: the relationship with inflammation and clinical parameters. Rheumatol Int 34:1153\u20131157","journal-title":"Rheumatol Int"},{"key":"10171_CR131","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbr.2016.07.009","volume":"313","author":"SH Su","year":"2016","unstructured":"Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J (2016) Cannabinoid receptor agonist WIN55,212\u20132 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K\/AKT signaling. Behav Brain Res 313:334\u2013344","journal-title":"Behav Brain Res"},{"key":"10171_CR132","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/aps.2012.141","volume":"34","author":"J Sun","year":"2013","unstructured":"Sun J, Fang YQ, Ren H et al (2013) WIN55,212\u20132 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats. Acta Pharmacol Sin 34:119\u2013128","journal-title":"Acta Pharmacol Sin"},{"key":"10171_CR133","doi-asserted-by":"publisher","first-page":"112418","DOI":"10.1016\/j.bbr.2019.112418","volume":"380","author":"N Syeara","year":"2020","unstructured":"Syeara N, Alamri FF, Jayaraman S, Lee P, Karamyan ST, Arumugam TV et al (2020) Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke. Behav Brain Res 380:112418","journal-title":"Behav Brain Res"},{"key":"10171_CR134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fneur.2020.00087","volume":"11","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Sackett S, Zhang Y (2020) Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology. Front Neurol 11:87","journal-title":"Front Neurol"},{"key":"10171_CR135","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/jnc.13833","volume":"139","author":"X Tian","year":"2016","unstructured":"Tian X, Peng J, Zhong J et al (2016) beta-Caryophyllene protects in vitro neurovascular unit against oxygen-glucose deprivation and re-oxygenation-induced injury. J Neurochem 139:757\u2013768","journal-title":"J Neurochem"},{"key":"10171_CR136","first-page":"309","volume":"37","author":"RD Topuz","year":"2020","unstructured":"Topuz RD, Gunduz O, Karadag CH, Ulugol A (2020) Non-opioid Analgesics and the Endocannabinoid System. Balkan Med J 37:309\u2013315","journal-title":"Balkan Med J"},{"key":"10171_CR137","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.psychres.2018.06.012","volume":"267","author":"DP Wang","year":"2018","unstructured":"Wang DP, Yin H, Kang K, Lin Q, Su SH, Hai J (2018) The potential protective effects of cannabinoid receptor agonist WIN55,212\u20132 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia. Psychiatry Res 267:281\u2013288","journal-title":"Psychiatry Res"},{"issue":"10","key":"10171_CR138","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1161\/STROKEAHA.120.030486","volume":"51","author":"NS Ward","year":"2020","unstructured":"Ward NS, Carmichael ST (2020) Blowing up Neural Repair for Stroke Recovery: Preclinical and Clinical Trial Considerations. Stroke 51(10):3169\u20133173","journal-title":"Stroke"},{"key":"10171_CR139","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","volume":"185","author":"AY Wen","year":"2010","unstructured":"Wen AY, Sakamoto KM, Miller LS (2010) The role of the transcription factor CREB in immune function. J Immunol 185:6413\u20136419","journal-title":"J Immunol"},{"key":"10171_CR140","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/brb3.44","volume":"2","author":"JL Wilkerson","year":"2012","unstructured":"Wilkerson JL, Gentry KR, Dengler EC et al (2012) Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain Behav 2:155\u2013177","journal-title":"Brain Behav"},{"key":"10171_CR141","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0022-3565(24)36812-0","volume":"282","author":"KA Willoughby","year":"1997","unstructured":"Willoughby KA, Moore SF, Martin BR, Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243\u2013247","journal-title":"J Pharmacol Exp Ther"},{"key":"10171_CR142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnmol.2020.00028","volume":"13","author":"L Wu","year":"2020","unstructured":"Wu L, Xiong X, Wu X et al (2020) Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury. Front Mol Neurosci 13:28","journal-title":"Front Mol Neurosci"},{"key":"10171_CR143","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fnins.2017.00583","volume":"11","author":"M Yang","year":"2017","unstructured":"Yang M, Lv Y, Tian X et al (2017) Neuroprotective Effect of beta-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation In Vivo and in Vitro. Front Neurosci 11:583","journal-title":"Front Neurosci"},{"key":"10171_CR144","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.7150\/thno.35686","volume":"9","author":"Q Yang","year":"2019","unstructured":"Yang Q, Ren GL, Wei B et al (2019) Conditional knockout of TGF-betaRII \/Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation. Theranostics 9:8277\u20138293","journal-title":"Theranostics"},{"key":"10171_CR145","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fncel.2019.00127","volume":"13","author":"Y Ye","year":"2019","unstructured":"Ye Y, Zeng Z, Jin T, Zhang H, Xiong X, Gu L (2019) The Role of High Mobility Group Box 1 in Ischemic Stroke. Front Cell Neurosci 13:127","journal-title":"Front Cell Neurosci"},{"key":"10171_CR146","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.3390\/ijms22062866","volume":"22","author":"CG Yokubaitis","year":"2021","unstructured":"Yokubaitis CG, Jessani HN, Li H, Amodea AK, Ward SJ (2021) Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia. Int J Mol Sci 22:2866","journal-title":"Int J Mol Sci"},{"key":"10171_CR147","doi-asserted-by":"publisher","first-page":"e0132487","DOI":"10.1371\/journal.pone.0132487","volume":"10","author":"SJ Yu","year":"2015","unstructured":"Yu SJ, Reiner D, Shen H, Wu KJ, Liu QR, Wang Y (2015) Time-Dependent Protection of CB2 Receptor Agonist in Stroke. PLoS ONE 10:e0132487","journal-title":"PLoS ONE"},{"key":"10171_CR148","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/brainsci13030525","volume":"13","author":"MH Yu","year":"2023","unstructured":"Yu MH, Yang Q, Zhang YP et al (2023) Cannabinoid Receptor Agonist WIN55, 212\u20132 Attenuates Injury in the Hippocampus of Rats after Deep Hypothermic Circulatory Arrest. Brain Sci 13:525","journal-title":"Brain Sci"},{"key":"10171_CR149","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/STROKEAHA.111.631044","volume":"43","author":"JG Zarruk","year":"2012","unstructured":"Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I et al (2012) Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage\/microglial activation concomitant to neuroprotection. Stroke 43:211\u2013219","journal-title":"Stroke"},{"key":"10171_CR150","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.jcbfm.9600447","volume":"27","author":"M Zhang","year":"2007","unstructured":"Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF (2007a) Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia\/reperfusion model. J Cereb Blood Flow Metab 27:1387\u20131396","journal-title":"J Cereb Blood Flow Metab"},{"key":"10171_CR151","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.expneurol.2007.01.015","volume":"204","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Milatovic D, Aschner M, Feustel PJ, Kimelberg HK (2007b) Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity. Exp Neurol 204:819\u2013827","journal-title":"Exp Neurol"},{"key":"10171_CR152","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mvr.2009.03.005","volume":"78","author":"M Zhang","year":"2009","unstructured":"Zhang M, Adler MW, Abood ME, Ganea D, Jallo J, Tuma RF (2009) CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic\/reperfusion injury. Microvasc Res 78:86\u201394","journal-title":"Microvasc Res"},{"key":"10171_CR153","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/1535370218757950","volume":"243","author":"D Zhang","year":"2018","unstructured":"Zhang D, Zhang G, Li Z, Li B (2018) Activation of the cannabinoid receptor 1 by ACEA suppresses senescence in human primary chondrocytes through sirt1 activation. Exp Biol Med (Maywood) 243:437\u2013443","journal-title":"Exp Biol Med (Maywood)"},{"key":"10171_CR154","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/jnen\/63.9.964","volume":"63","author":"W Zhao","year":"2004","unstructured":"Zhao W, Xie W, Le W et al (2004) Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 63:964\u2013977","journal-title":"J Neuropathol Exp Neurol"},{"key":"10171_CR155","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuroscience.2017.02.027","volume":"348","author":"H Zhao","year":"2017","unstructured":"Zhao H, Chen S, Gao K et al (2017) Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1\/AMPK signaling pathway. Neuroscience 348:241\u2013251","journal-title":"Neuroscience"},{"key":"10171_CR156","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2014.07.013","volume":"35","author":"W Zhou","year":"2014","unstructured":"Zhou W, Yuan J (2014) Necroptosis in health and diseases. Semin Cell Dev Biol 35:14\u201323","journal-title":"Semin Cell Dev Biol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-025-10171-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:51:07Z","timestamp":1738565467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-025-10171-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":156,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10171"],"URL":"https:\/\/doi.org\/10.1007\/s11481-025-10171-z","relation":{},"ISSN":["1557-1904"],"issn-type":[{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12"}}